Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerie, Amydis, Axcella, Boehringer, Chipscreen, Cytokinetics, Editas, Eli Lilly, Ideaya, Istari, Exicure, Lysogene, Neuren, Obseva, Organogenesis, RDIF, Receptor Life Sciences, Roche.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anavex, Baxter, Biogen, Bioinvent, Cohbar, Curevac, Cyclolab, Dyne, Epipharma, Exuma, Geovax, Hoth, Humanigen, Legochem, Maxcyte, Mirati, Moderna, Myeloid, Navrogen, Novavax, Opiant, Pharmabcine, Resolution Bioscience, Targetrin.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Aptevo, Aslan, Biomarin, Can-Fite, Cara, Celon, Codagenix, Dalcor, Dr. Reddy's, Edesa, Inflarx, Jupiter Orphan, Kintor, Lilly, Mediwound, Mesoblast, Neurorx, Oric, Redhill, Relief, Ultimovacs.

The latest global regulatory news, changes and updates affecting biopharma, including: Drug safety in pregnancy mission of new U.K. consortium; FDA identifies regulatory science needs; HHS finalizes regulatory review rule; Doctor pleads guilty to trial fraud.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA formally posts testing advisory after town hall discussion; HHS finalizes regulatory review rule; Lab in California hit for three months of false claims; BVMed calls for German med tech strategy.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4basecare, Applied Biosystems, Applied DNA Sciences, Blue Note Therapeutics, Caredx, Crown Bioscience, Emulate, Labcorp, Myriad Genetics, Pacific Biosciences, Transchart.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Bayer, Glaxosmithkline, Medicure, Merus, Moderna, Neoleukin.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adverum, Aquestive, Avidity, Baliopharm, Bayer, Biogen, Biontech, Bristol Myers, Celularity, Cevec, GX, Integral, Microbiome, Novavax, Novozymes, Oncternal, Optimeos, Pfizer, Sareum, Vincera, Vincerx, Xlife.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiowise, Locate Bio, Siemens Healthineers.